Connecticut Opens Psychedelic Therapy Pilot To More Adults As Demand Grows
Connecticut is widening access to a medical psychedelic therapy program at a moment when public interest has clearly outpaced availability.
Read More
Nearly 5 Million Veterans Have Tried Psychedelics, RAND Study Finds
Psychedelics are no longer a fringe topic among veterans. They are part of the lived experience of millions of those who serve in the military.
Read More
American Society of Anesthesiologists Calls For Stronger Ketamine Oversight As Use Surges
One of the country’s most influential anesthesia groups is warning that ketamine telehealth's safety standards have not kept pace.
Read More
What Todd Blanche’s Attorney General Nomination Could Mean for Psychedelics
A recent JD Supra analysis looks at what Todd Blanche’s nomination for attorney general could mean for marijuana and psychedelic policy.
Read More
Connecticut Expands Its Psychedelic Therapy Pilot Program Ahead of Possible Federal Approval
Gov. Ned Lamont has signed Senate Bill 191, a measure that expands the state’s existing psychedelic therapy pilot program.
Read More
Insurance Trade Publication Urges Insurers to Prepare for Psychedelic Medicine
Insurance Business, a trade publication for the insurance sector, is now telling insurers to pay closer attention to psychedelic medicine. In a recent column, neuropsychopharmacologist Dr. Rayyan Zafar argued that psychedelic therapies are moving from fringe science into clinical, commercial, and regulatory reality. His larger point was not subtle. Insurers should not wait for the […]
Read More
Michigan Rep. Jack Bergman Says Psychedelic Treatment Research Has Reached a New Moment
Rep. Jack Bergman, a Michigan Republican and one of Congress’s leading voices on psychedelics, says the window for action has opened wider.
Read More
Ohio Lawmakers Consider Ibogaine Research As Veterans Push For New PTSD And Addiction Options
The discussion, led through Ohio’s Ibogaine Treatment Study Committee, reflects a broader shift in psychedelic policy.
Read More
Lawmakers Push FDA to Speed Up Psychedelic Therapy Reviews
They asked the agency to advance evaluations of rapid acting therapeutics for PTSD, traumatic brain injury and related conditions.
Read More
From LSD Hearings to Trump’s Psychedelic Order: A 60 Year Timeline of Washington’s Evolving View of Psychedelics
Here's a timeline of Washington's evolving view on psychedelics. From LSD research to the War on Drugs to today’s push for mental health.
Read More